Literature DB >> 20860740

Clinical course of guttate psoriasis: long-term follow-up study.

Hyun-Chang Ko1, Seung-Wook Jwa, Margaret Song, Moon-Bum Kim, Kyung-Sool Kwon.   

Abstract

Guttate psoriasis, known to have a better prognosis than other types of psoriasis, shows rapid involution and longer remission, but its clinical course has barely been studied. The aim of this study was to determine the clinical course and to compare the clinical and laboratory features of guttate psoriasis. This is a retrospective study of 26 patients with guttate psoriasis. The patients were divided into two groups; the good one with complete remission and long remission for at least 1 year (group A) and the poor one with incomplete remission and progression into chronic plaque psoriasis (group B). Among 36 patients, 22 patients (61.1%) were group A and 14 patients (38.9%) were group B. In group A, most of the skin lesions disappeared within 8 months. In group B, two patients without proper treatment progressed to plaque psoriasis. The onset age was younger and more frequent upper respiratory infection and high anti-streptolysin O (ASO) titer were found in group A, but family history of psoriasis was more common in group B. Patients had two distingushable clinical courses: rapid involuting course with long-term remission and chronic course without remission. There was a tendency toward younger age of onset with elevated ASO titer in patients with rapid involuting course.
© 2010 Japanese Dermatological Association.

Entities:  

Mesh:

Year:  2010        PMID: 20860740     DOI: 10.1111/j.1346-8138.2010.00871.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  10 in total

1.  Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.

Authors:  Annabel Maruani; Mahtab Samimi; Natasha Stembridge; Rania Abdel Hay; Elsa Tavernier; Carolyn Hughes; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2019-04-08

2.  A case series of early biologic therapy in guttate psoriasis: Targeting resident memory T cell activity as a potential novel therapeutic modality.

Authors:  Akshay Flora; John W Frew
Journal:  JAAD Case Rep       Date:  2022-05-05

3.  Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.

Authors:  Hyun Jeong Ju; Hyo Jin Park; In Hye Choi; Kyung Ho Lee; Mi Yeon Kwon; Chul Jong Park
Journal:  Ann Dermatol       Date:  2022-05-20       Impact factor: 0.722

4.  Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States.

Authors:  Katherine Mercy; Mary Kwasny; Kelly M Cordoro; Alan Menter; Wynnis L Tom; Neil Korman; Leah Belazarian; April W Armstrong; Moise L Levy; Amy S Paller
Journal:  Pediatr Dermatol       Date:  2013-01-30       Impact factor: 1.588

5.  Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series.

Authors:  Grace C Brummer; Jason E Hawkes; Kristina Callis Duffin
Journal:  JAAD Case Rep       Date:  2017-09-01

Review 6.  Skin manifestations in spondyloarthritis.

Authors:  Katharina Meier; Alexandra Schloegl; Denis Poddubnyy; Kamran Ghoreschi
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

7.  Recommendations for Management of Childhood Psoriasis.

Authors:  Bhumesh Kumar Katakam; Malathi Munisamy; T Narayana Rao; Minu Jose Chiramel; Maitreyee Panda; Sandeep Gupta; Ranugha Pss; K A Seetharam
Journal:  Indian Dermatol Online J       Date:  2021-11-25

8.  SARS-CoV-2 and guttate psoriasis: A case report and review of literature.

Authors:  Elrazi Ali; Abdelaziz Mohamed; Joud Abuodeh; Mhd Kutaiba Albuni; Najlaa Al-Mannai; Sarah Salameh; Mahir Petkar; Elmukhtar Habas
Journal:  Clin Case Rep       Date:  2021-07-16

9.  Guttate psoriasis secondary to COVID-19.

Authors:  Kohilan Gananandan; Benjamin Sacks; Iain Ewing
Journal:  BMJ Case Rep       Date:  2020-08-11

Review 10.  Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.

Authors:  Robert Gironés Petit; Amanda Cano; Alba Ortiz; Marta Espina; Josefina Prat; Montserrat Muñoz; Patrícia Severino; Eliana B Souto; Maria L García; Montserrat Pujol; Elena Sánchez-López
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.